Migraine prophylactic drugs work via ion channels

Medical Hypotheses

Volumn 65, Issue 1, 2005, Pages 114-122

  Cohen, Gary L ^a  

^a MARSHFIELD CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACEBUTOLOL; ACETAZOLAMIDE; AMITRIPTYLINE; ANTICONVULSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; BUPIVACAINE; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; DESIPRAMINE; DILTIAZEM; DOXEPIN; FLUNARIZINE; FLUOXETINE; GABAPENTIN; IMIPRAMINE; LAMOTRIGINE; LIDOCAINE; MAPROTILINE; MEXILETINE; NADOLOL; NICARDIPINE; NIFEDIPINE; NIMODIPINE; NORTRIPTYLINE; PAROXETINE; PHENOBARBITAL; PHENYTOIN; PINDOLOL; PROPRANOLOL; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SODIUM CHANNEL; TIMOLOL; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIIMIPRAMINE; UNCLASSIFIED DRUG; VALPROIC ACID; VERAPAMIL; VERATRIDINE; ZONISAMIDE;

CARDIOTOXICITY; CLINICAL TRIAL; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG POTENCY; DRUG POTENTIATION; HEADACHE; HUMAN; HYPOTHESIS; LOW DRUG DOSE; MEDICAL RESEARCH; MIGRAINE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEROTONINERGIC SYSTEM; SIDE EFFECT; SYNAPTIC TRANSMISSION;

EID: 18944379387     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2005.01.027     Document Type: Article

References (70)

1. E.L.H. Spierings Mechanism of migraine and action of antimigraine medications Med Clinic North Am 85 4 2001 943 957
2. H.G. Wolff Headache and other head pain 2nd ed. 1963 Oxford University Press
3. J. Olesen, B. Larsen, and M. Lauritzen Focal hyperemia followed by spreading oligemia and impaired activation of RCBF in classic migraine Ann Neurol 9 1981 344 352
4. M. Lauritzen Long-lasting reduction of cortical blood flow of the rat brain after spreading depression with preserved autoregulation and impaired CO2 response J Cereb Blood Flow Metabol 4 1984 546 554
5. A.A.P. Leao Spreading depression of activity in cerebral cortex J Neurophys 7 1944 359 390
6. C. Weiller, A. May, and V. Limmroth Brain stem activation in spontaneous human migraine attacks Nat Med 1 7 1995 658 661
7. K.M.A. Welch, G. D'Andrea, and N. Tepley The concept of migraine as state of central neuronal hyperexcitability Neurol Clin 8 4 1990 817 828
8. S. Markowitz, S. Saito, and M.A. Moskowitz Neurogenically mediated plasma extravasation in dura mater: effect of ergot alkaloids: a possible mechanism in vascular headache Cephalalgia 8 1988 83 91
9. R. Burstein, F.M. Cutret, and D. Yarnitsky The development of cutaneous allodynia during a migraine attack Brain 123 2000 1703 1709
10. A.M. Strassman, S.A. Raymond, and R. Burstein Sensitization of meningeal sensory neurons and the origins of headaches Lett Nat 384 1996 560 564
11. L.J. Ptacek, and Y.H. Fui Channels and disease. Past, present, and future Arch Neurol 61 2004 1665 1668
12. D.M. Kullmann The neuronal channelopathies Brain 125 2002 1177 1195
13. J.C. Jen, G.W. Kim, and K.A. Dudding No mutations in CACNA1A and ATP1A2 in probands with common types of migraine Arch Neurol 61 2004 926 928
14. Hille, B. Ionic channels of excitable membranes. 2nd ed. Sinauer; 1992
15. W.A. Catterall, K.G. Chandy, and D.E. Clapham International union of pharmacology: approaches to the nomenclature of voltage-gated ion channels Pharm Rev 55 2003 573 574
16. M.J. Craner, J.P. Klein, and M. Renganathan Changes of sodium channel expression in experimental painful diabetic neuropathy Ann Neurol 52 2002 786 792
17. M.A. Rogawski, and W. Loscher The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions Nat Med 10 7 2004 685 692
18. S.D. Silberstein Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review) Report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology 55 2000 754 763
19. S.D. Silberstein, and P.J. Goadsby Migraine: preventive treatment Cephalalgia 22 2002 491 512
20. J.R. Couch, D.K. Ziegler, and R.S. Hassanein Amitriptyline in the prophylaxis of migraine Neurology 26 1976 121 127
21. G.M. Nicholson, T. Blanche, and K. Mansfield Differential blockade of neuronal voltage-gated Na(+) and K(+) channels by antidepressant drugs Eur J Pharmacol 457 1 2002 35 48
22. P. Gerner, A.E. Haderer, and M. Mujitaba Assessment of differential blockade by amitriptyline and its N-methyl derivative in different species by different routes Anesthesiology 98 2003 1484 1490
23. P. Gerner, M. Mujitaba, and C.J. Sinnott Amitriptyline versus bupivacaine rat sciatic nerve blockade Anesthesiology 94 2001 661 667
24. M.E. Brau, M. Dreimann, and A. Olschewski Effect of drugs used for neuropathic pain management on tetrodotoxin-resistant Na+ currents in rat sensory neurons Anesthesiology 94 2001 137 144
25. Y. Sudoh, E.E. Cahoon, and P. Gerner Tricyclic antidepressants as long-acting local anesthetics Pain 103 2003 49 55
26. C.S. Barnet, J.Y. Tse, and D.S. Kohane Site 1 sodium channel blockers prolong the duration of sciatic nerve blockade from tricyclic antidepressants Pain 110 1-2 2004 432 438
27. S.H. Presskorn Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphais on pharmacokinetics and effects on oxidative drug metabolism Clin Pharmacokinet 32 Suppl 1 1997 1 21
28. S.J. Hahn, J.S. Choi, and D.J. Rhie Inhibition by fluoxetine of voltage-gated ion channels in rat PC12 cells Eur J Pharmacol 367 1 1999 113 118
29. J.J. Pancrazio, G.L. Kamatchi, and A.K. Roscoe Inhibition of neuronal Na+ channels by antidepressant drugs J Pharmacol Exp Ther 284 1998 208 214
30. N. Raskin Headache 2nd ed. 1991 Churchill Livingstone p. 161
31. Hardman JG, Limbird LL, editors in chief. Goodman and Gilman's. The pharmacological basis of therapeutics. 9th ed. McGraw-Hill; 1996. p. 852
32. J.C. Matthews, and J.K. Baker Effects of propanolol and a number of its analogues on sodium channels Biochem Pharmacol 31 9 1982 1681 1685
33. G. Chidlow, J. Melena, and N. Osborne Betaxolol, a beta(1)-adrenoceptor antagonist, reduces Na(+) influx into cortical synaptosomes by direct action with Na(+) channels: comparison with other beta-adrenoceptor antagonists Br J Pharmacol 130 4 2000 759 766
34. H. Hashizume, K. Akiyama, and Y. Abiko Effects of antiischemic drugs on ceratridine-induced hypercontracture in rat cardiac myocytes Eur J Pharmacol 271 1 1994 1 8
35. G.D. Solomon Verapamil in migraine prophylaxis: a five year review Headache 29 1989 425 427
36. B.G. Katzung Basic and clinical pharmacology 8th ed. 2001 Lange Medical Books/McGraw-Hill
37. F.L. Smith, R.W. Davis, and R. Carter Influence of voltage-sensitive Ca++ channel drugs on bupivacaine infiltration anesthesia in mice Anesthesiology 95 2001 1189 1197
38. A.S. Arbab, K. Koizumi, and K. Toyama Effects of ion channel modulators in the influx and efflux of Tc-99m-MIDI Ann Nucl Med Feb 13 1 1999 27 32
39. W. Fischer, H. Kittner, and R. Regenthal Anticonvulsant profile of flunarizine and relation to Na(+) channel blocking effects Basic Clin Pharmacol Toxicol 94 2 2004 79 88
40. N.I. Kiskin, I.V. Chizhmakov, and A.Y. Tsyndrenko R56865 and flunarizine as Na(+)-channel blockers in isolated Purkinje neurons of rat cerebellum Neuroscience 54 3 1993 575 585
41. R. Hering, and A. Keritsky Sodium valproate in the prophylactic treatment of migraine: a double blind study versus placebo Cephalalgia 12 1992 81 84
42. S.R. Chebabo, and R.J. Do Carmo Phenytoin and retinal spreading depression Brain Res 551 1-2 1991 16 19
43. R. Grahame Drug prophylaxis in migraine, a controlled clinical trial Brit Med J 5207 1960 1203 1207
44. R.L. Macdonald, and K.M. Kelly Mechanisms of action of currently prescribed and newly developed antiepileptic drugs Epilepsia 35 Suppl. 4 1994 S41 S50
45. M. Willow, and W.A. Catterall Inhibition of (3H)batrachotoxin A 20-a-benzoate to sodium channels by the anticonvulsant drugs diphenylhydantoin and carbamazapine Mol Pharmacol 22 1982 627 635
46. M.K. Pugsley, E.J. Yu, and T.H. McLean Blockade of neuronal sodium channels by the antiepileptic drugs phenytoin, carbamazapine and sodium valproate Proc West Pharmacol Soc 42 1999 105 108
47. M. Vreugdenhil, and W.J. Wadman Modulation of sodium currents in rat CA1 neurons by carbamazapine and valproate after kindling epileptogenesis Epilepsia 40 11 1999 1512 1522
48. W. Loscher Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action Prog Neurobiol 58 1999 31 59
49. J.M. Rho, and R. Sankar The pharmacologic basis of antiepileptic drug action Epilepsia 40 11 1999 1471 1483
50. H. Morita, J. Shi, and Y. Ito T-channel-like pharmacological properties of high voltage-activated, nifedipine-insensitive Ca2+ currents in the rat terminal mesenteric artery Brit J Pharmacol 137 4 2002 467 476
51. N. Mathew, A. Rapoport, and J. Saper Efficacy of gabapentin in migraine prophylaxis Headache 41 2001 119 128
52. M.A. Rose, and P.C.A. Kam Gabapentin: pharmacology and its use in pain management Anaesthesia 57 2002 451 462
53. A.W. Wamil, and M.J. McLean Limitation by gabapentin of high frequency action potential firing by mouse central neurons in cell culture Epilepsy Res 17 1994 1 11
54. A. Stefani, F. Spadoni, and P. Giacomini The effects of gabapentin on different ligand- and voltage-gated currents in isolated cortical neurons Epilepsy Res 43 2001 239 248
55. N.S. Gee, J.P. Brown, and V.U. Dissanayake The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha two-delta subunit of a calcium channel J Biol Chem 27 1996 5768 5776
56. M. Oka, Y. Itoh, and M. Wada A comparison of Ca2+ channel blocking mode between gabapentin and verapamil: implication for protection against hypoxic injury in rat cerebrocortical slices Br J Pharmacol 139 2003 435 443
57. D.J. Martin, D. McClelland, and M.B. Herd Gabapentin-mediated inhibition of voltage-activated Ca2+ channel currents in cultured sensory neurons is dependent on culture conditions and channel subunit expression Neuropharmacol 42 2002 353 366
58. K. Fink, D.J. Dooley, and W.P. Meder Inhibition of neuronal Ca2+ influx by gabapentin and pregabilin in the human neocortex Neuropharmacology 42 2002 229 236
59. J. Brandes, J.R. Saper, and M. Diamond Topiramate for migraine prevention: a randomized controlled trial J Am Med Assoc 291 2004 965 973
60. R.P. Shank, J.F. Gardocki, and A.J. Streeter An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action Epilepsia 41 Suppl. 1 2000 S3 S9
61. R.J. DeLorenzo, A. Sombati, and D.A. Coulter Effects of topiramate on sustained repetitive firing and spontaneous recurrent seizure discharges in cultured hippocampal neurons Epilepsia 41 Suppl. 1 2000 S40 S44
62. M.J. McLean, A.A. Bukhari, and A.W. Wamil Effects of topiramate on sodium-depent action potential firing by mouse spinal cord neurons in cell culture Epilepsia 41 Suppl. 1 2000 S21 S24
63. X. Zhang, A.A. Velumian, and O.T. Jones Modulation of high-voltage-activated calcium channels in dentate gyrus cells by topiramate Epilepsia 41 Suppl. 1 2000 S52 S60
64. G. D'Andrea, F. Granella, and M. Cadalini Effectiveness of lamotrigine in the prophylaxis of migraine with aura: an open pilot study Cephalalgia 19 1 1999 64 66
65. J. Pascual, A.B. Caminero, and V. Mateos Preventing disturbing migraine aura with lamotrigine: an open study Headache 44 10 2004 1024 1028
66. G. Liu, V. Yarov-Yarovoy, and M. Nobbs Differential interactions of lamotrigine and related drugs with transmembrane segment IVS6 of voltage-gated sodium channels Neuropharmacology 44 2003 413 422
67. A.H. Hainsworth, F. Spadoni, and F. Lavaroni Effects of extracellular pH on the interaction of sipatrigine and lamotrigine with high-voltage-regulated calcium channels in dissociated neurons of rat cortex Neuropharmacology 40 6 2001 784 791
68. S. Evers, J. Vollmer-Haase, and S. Schwaag Botulinum toxin A in the prophylactic treatment of migraine - a randomized, double-blind, placebo-controlled study Headache 44 10 2004 838 843
69. M. Maizels, and A.M. Geiger Intranasal lidocaine for migraine: a randomized trial and open-label follow-up Headache 39 8 1999 543 551
70. D.R. Williams, and R.J. Stark Intravenous lignocaine (lidocaine) infusion for the treatment of chronic daily headache with substantial medication overuse Cephalalgia 23 10 2003 963 971